DLC1 negatively regulates angiogenesis in a paracrine fashion

Yi-Ping Shih1, Yi-Chun Liao, Yuan Lin

  • 1Department of Biochemistry and Molecular Medicine, Center for Tissue Regeneration and Repair, University of California-Davis, Sacramento, California 95817, USA.

Cancer Research
|September 24, 2010
PubMed

Insights

Loss of DLC1 tumor suppressor in prostate cells promotes angiogenesis via VEGF upregulation, not direct tumor growth. This suggests DLC1 loss acts as a "second hit" in cancer progression.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • The Rho GTPase-activating protein DLC1 functions as a tumor suppressor, frequently deleted in liver cancer and downregulated in other malignancies.
  • DLC1 regulates critical cellular processes including the actin cytoskeleton, cell shape, adhesion, migration, and proliferation.

Purpose of the Study:

  • To investigate the tumor suppressive functions of DLC1 by silencing it in nonmalignant prostate epithelial cells.
  • To elucidate the molecular mechanisms underlying DLC1's role in prostate cancer development and progression.

Main Methods:

  • Small hairpin RNA (shRNA) was used to silence DLC1 expression in prostate epithelial cells.
  • Vascular Endothelial Growth Factor (VEGF) and Hypoxia-Inducible Factor 1α (HIF-1α) levels were assessed following DLC1 silencing.
  • Signaling pathways involving Epidermal Growth Factor Receptor (EGFR), MAP/ERK kinase (MEK), and RhoA were analyzed.

Main Results:

  • DLC1 silencing did not promote aggressive tumor cell growth phenotypes.
  • DLC1 silencing led to increased pro-angiogenic responses, evidenced by Vascular Endothelial Growth Factor (VEGF) upregulation.
  • VEGF upregulation was associated with increased accumulation and nuclear localization of Hypoxia-Inducible Factor 1α (HIF-1α).
  • Modulation of VEGF by DLC1 involved EGFR-MAP/ERK kinase-HIF-1 signaling, independent of RhoA pathways.

Conclusions:

  • Loss of DLC1 in prostate cells promotes angiogenesis through VEGF upregulation, potentially via EGFR-MAPK-HIF-1 signaling.
  • Clinical data shows a significant correlation between VEGF upregulation and DLC1 downregulation in prostate cancers.
  • The downregulation of DLC1 may act as a critical 'second hit' facilitating tumor angiogenesis in a paracrine manner during tumorigenesis.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which results in tumor...
Paracrine Signaling01:21

Paracrine Signaling

Paracrine signaling allows cells to communicate with their immediate neighbors via secretion of signaling molecules. Such a signal can only trigger a response in nearby target cells because the signal molecules degrade quickly or are inactivated if not taken up. Prominent examples of paracrine signaling include nitric oxide signaling in blood vessels, synaptic signaling of neurons, the blood clotting system, tissue repair/wound healing, and local allergic skin reactions. Nitric oxide as a...
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...